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Strengths and limitations of this study
 ► The linked database will serve as a basis for future 
studies unique to tropical Australia of incidence, risk 
factors and clinical outcomes of patients with hospi-
tal admissions involving infectious diseases.
 ► The incorporation of pathology results in the cohort 
will allow precise characterisation of many infec-
tious diseases.
 ► The patient cohort was based on data sets from a 
single hospital, findings might not be generalisable 
to the Australian population.
 ► The validity of cohort studies rely on the accuracy 
of clinical coding; therefore, some important clinical 
information may be underrepresented.
AbStrACt
Purpose To design a linked hospital database using 
administrative and clinical information to describe 
associations that predict infectious diseases outcomes, 
including long- term mortality.
Participants A retrospective cohort of Townsville Hospital 
inpatients discharged with an International Classification 
of Diseases and Related Health Problems 10th Revision 
Australian Modification code for an infectious disease 
between 1 January 2006 and 31 December 2016 was 
assembled. This used linked anonymised data from: 
hospital administrative sources, diagnostic pathology, 
pharmacy dispensing, public health and the National 
Death Registry. A Created Study ID was used as the 
central identifier to provide associations between the 
cohort patients and the subsets of granular data which 
were processed into a relational database. A web- based 
interface was constructed to allow data extraction and 
evaluation to be performed using editable Structured 
Query Language.
Findings to date The database has linked information on 
41 367 patients with 378 487 admissions and 1 869 239 
diagnostic/procedure codes. Scripts used to create the 
database contents generated over 24 000 000 database 
rows from the supplied data. Nearly 15% of the cohort was 
identified as Aboriginal or Torres Strait Islanders. Invasive 
staphylococcal, pneumococcal and Group A streptococcal 
infections and influenza were common in this cohort. The 
most common comorbidities were smoking (43.95%), 
diabetes (24.73%), chronic renal disease (17.93%), cancer 
(16.45%) and chronic pulmonary disease (12.42%). 
Mortality over the 11- year period was 20%.
Future plans This complex relational database reutilising 
hospital information describes a cohort from a single 
tropical Australian hospital of inpatients with infectious 
diseases. In future analyses, we plan to explore analyses of 
risks, clinical outcomes, healthcare costs and antimicrobial 
side effects in site and organism specific infections.
IntroduCtIon
Deriving a broad and detailed understanding 
of the epidemiology of infectious diseases 
is crucial as they are a common cause of 
admissions to hospitals and frequent cause of 
hospital complications. In 2016–2017, 7.2 per 
1000 of Australia’s population were hospital-
ised with a primary diagnosis of an infectious 
disease.1 The rate in Australia’s Indigenous 
population was double this. Of the prin-
cipal causes of hospitalisation, pneumonia 
was fourth, cellulitis ninth and ‘other sepsis’ 
16th. Regrettably, 103 000 patient episodes 
(1.2% of all hospital separations) involved 
a hospital- acquired infection. Urinary tract 
infection, pneumonia and blood stream 
infection are the third to fifth most common 
hospital- acquired complications. These infec-
tions contribute to the marked increase in the 
average length of stay (17 vs 4.4 days)1 and 
may increase mortality.2 Patterns of mortality 
for various illnesses, chronic and acute, are 
documented by the Australian Institute of 
Health and Welfare. Infectious and parasitic 
diseases (narrowly defined) are relatively 
infrequent single causes of mortality (<3%).3 
However, more commonly, they are contrib-
utors to multiple causes of death in patients 
with chronic conditions. For instance, pneu-
monia and influenza are particularly common 
causes of death in patients with dementia.
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Currently, there exists an opportunity to reutilise large 
amounts of data collected for administrative and routine 
clinical purposes to derive a more detailed picture of 
the incidence of diseases in Australian hospitals.4 Data- 
linkage processes are a powerful tool for analysis of various 
disease cohorts. These are a value- adding re- use of previ-
ously acquired patient information that represents a rich 
research resource. We have developed a database that will 
be used in the future to analyse the incidence, risk factors 
and clinical outcomes of patients with hospital admissions 
involving infectious disease.
Cohort deSCrIPtIon
Setting
The Townsville Hospital is the tertiary referral centre for 
North Queensland, providing specialist care for 670 000 
people. Townsville is located at 19.26° S and has a ‘dry 
tropics’ climate with a mean rainfall of 1100 mm.
Cohort selection
A cohort of Townsville Hospital inpatients was identi-
fied based on International Classification of Diseases and 
Related Health Problems 10th Revision Australian Modi-
fication (ICD-10- AM) discharge codes for an infectious 
disease. The cohort spanned for the 11- year period from 1 
January 2006 to 31 December 2016. Information from the 
episode of care that led to cohort inclusion and all previous 
and subsequent inpatient admissions was provided.
The ICD-10- AM codes primarily used to select the 
patient cohort were infectious and parasitic diseases 
(A00–B99) (online supplementary table S1). However, 
for completeness, selected infection- related codes were 
also included from:
 ► Diseases of the nervous system G* describing intracra-
nial infection.
 ► Diseases of the eye, ear and mastoid process H* 
describing intraocular and ear infection.
 ► Diseases of the circulatory system I* describing cardiac 
infections.
 ► Diseases of the respiratory system J* describing upper 
and lower respiratory tract infections.
 ► Diseases of the digestive system K* describing intra- 
abdominal infections.
 ► Diseases of the skin and subcutaneous tissues L* 
describing skin and soft tissue infections.
 ► Diseases of the musculoskeletal system and connective 
tissue M* describing infections of the bony skeleton 
and muscles.
 ► Diseases of the genitourinary system N* describing 
urinary tract infections.
 ► Symptoms, signs and abnormal clinical and labora-
tory findings, not elsewhere classified R* describing 
fever of unknown origin and shock among others.
databases
The following key data relating to the selected cohort 
were provided with the approval of Queensland Govern-
ment Data Custodians:
 ► Queensland Health Admitted Patient Data Collec-
tion (QHAPDC): patient demographics, Indigenous 
status, principal and other diagnoses ICD-10- AM 
codes, procedure codes using Australian Classification 
of Health Interventions, length of stay and hospital 
separation.
Admitted patient clinical coding is regulated by 
National Australian Coding Standards and QHAPDC 
data quality is managed via systematic internal audit, 
the State Government Queensland Audit Office and 
through periodic external audits.
 ► Date, primary and secondary causes of death over the 
11- year study period.
 ► Emergency data collection: triage category, principal 
and other diagnoses.
 ► Pathology: results for; general microbiology, infective 
serology testing, infective PCR testing; haematology, 
full blood examination, coagulation; biochemistry 
results, urea and electrolytes, liver function tests, C- re-
active protein.
 ► Antimicrobial dispensing: ipharmacy (central phar-
macy dispensing) and Pyxis (ward dispensing); 
dose, date and price of selected anti- infective drug 
dispensing.
 ► Notifiable Conditions System: type and site of 
infection.
data linkage
Extracted patient information was identifiable by the 
Medical Records Number. This was used by the Health 
Statistics Branch of Queensland Health to perform data- 
linkage processes described in the Queensland Data 
Linkage Framework. Anonymised data, identified by a 
unique Created Study ID, were provided to the research 
team.
database construction
The data were supplied variously as comma or tab delim-
ited text or as spreadsheet documents, and was processed 
into a relational database. The Created Study ID (PU_ID) 
was used as the central identifier to provide associations 
between the cohort patients and the subsets of granular 
data.
A web- based interface was constructed to allow data 
extraction and evaluation to be performed using either 
editable Structured Query Language or a selection of 
preset queries. The script and analysis interface were 
written in PHP/MySQL using a text editor.
data analysis
Patient data extracts for analysis were imported into SAS 
V.9.4. Descriptive summaries are presented as frequen-
cies and percentages for categorical variables, and means, 
quartiles and SDs for continuous variables. Charlson 
Comorbidity Index (CCI)5 6 was used to rank patient 
illness severity based on the number and importance of 
comorbid diseases (online supplementary table S2).
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Patient and public involvement statement
Patients or members of the public were not involved in the 
development and design of the research. The anonymised 
data extraction does not require patient recruitment.
reSultS
Cohort profile and database characteristics
The database consisted of linked information from 41 
367 patients with 378 487 admissions and 1 869 239 diag-
nostic or procedure codes. The ICD-10- AM codes for 
infectious diseases that were used to select patients for 
inclusion in the cohort are listed in online supplemen-
tary table S1. A summary of the data and the datafields 
is included in online supplementary table S2. The indi-
vidual datafields are listed in online supplementary table 
S3. The ICD-10- AM codes used to identify comorbidities 
are listed in online supplementary table S4. A database 
structure was designed to best accommodate the contents 
of the supplied data and the available identifiers within it. 
Its relational structure is shown in figure 1. The resulting 
relational structure was designed to provide total freedom 
to retrieve grouped patient information from all the 
component sources as a single data set.
The database contents were created using a variety of 
purpose- built scripts to process, reshape and clean the 
data. These scripts generated over 24 000 000 database 
rows from the supplied data. The Created Study ID (PU_
ID) was used as the central identifier to provide associa-
tions between the cohort patients and the data subsets.
Some assumptions were made during the processing 
of data. If pathology results were entered during the 
same date and time range as an admission, then this was 
included as part of the admission even though no admis-
sion identifier was available in the pathology data set.
Much of the collected data was entered as free text and 
preset values were inconsistently provided across different 
entry systems, resulting in variations in the expression of 
the same values. Scripts were written to standardise these 
results, extracting quantifiable values where possible. For 
example, the birth date of each person was not reliably 
supplied and the maximum detail was extracted from 
various data sources. Some sources using the same PU_
ID recorded the age inconsistently at a certain admis-
sion date, others had birth month and day, and others 
incorporated full birth dates. The scripts analysed and 
prioritised each of these and consolidated all available 
information for each of 41 367 people. The year of birth 
was successfully generated for every person. Additionally, 
the ICD-10- AM codes were not consistently entered. For 
example, ‘A064’ was entered but the correct format is 
‘A06.4’. Each was analysed, broken down into its compo-
nents and entered into the database. For 1130 of the 8274 
deaths, principal and other causes of death were listed 
as free text not ICD-10- AM codes. Causes of these deaths 
were coded manually.
Summary statistics are presented to give a basic descrip-
tion of the cohort (table 1). The distribution of age at first 
admission was skewed towards older subjects. Similarly, the 
total number of admissions was markedly skewed towards 
higher values. This is due to the significant number of 
haemodialysis patients who had a median of six admis-
sions with IQR of 2–41 over the 11- year duration of the 
cohort study. A large proportion of the patients identi-
fied as Indigenous (14.88%). Of interest, 4.5% of patients 
in this cohort were admitted to the Townsville Hospital 
from correctional facilities and Indigenous peoples are 
overrepresented among these patients compared with the 
cohort as a whole. The overall 11- year all- cause mortality 
was 20%. A high proportion of patients smoked (44%). 
Other major modifiable risk factors included alcohol 
abuse, obesity and malnutrition (table 1).
This patient cohort had a moderately low burden of 
comorbidity with an average CCI score of 1.86 (IQR, 
0–3). About 16% had a CCI of 5 and above. The major 
comorbidities are diabetes, cancer and renal disease. 
Other common comorbidities were chronic pulmonary 
disease, cerebrovascular disease and myocardial infarc-
tion. Multiple comorbidities were present in 67% of 
patients (table 2).
The geographic location of patient domicile as deter-
mined by postcode at the time of inpatient registration 
and numbers of patients per 100 000 resident in the Local 
Government Area are shown in figure 2. The majority of 
cohort patients resided in the Townsville Local Govern-
ment Areas.
Table 3 lists common infectious diseases diagnoses 
along with others of note in the tropical setting of Towns-
ville Hospital. These diagnoses represent aggregated 
codes that describe infection due to the same pathogen 
or the same site. Multiple codes often describe infection 
of the same organ. For common conditions such as Staph-
ylococcus aureus (A41), urinary tract infection (N39.0) and 
influenza and pneumonia (J09–J18), many diagnoses are 
coded as ‘other’. Precise study of these conditions, other 
microbial or organ specific infectious disease will require 
disaggregation of codes and incorporation of the avail-
able pathology results.
dISCuSSIon
This longitudinal cohort study describes patients 
discharged from the largest tertiary referral hospital in 
the tropical region of Australia with an infectious disease 
diagnosis. The infectious diseases included in this cohort 
represent an exhaustive list of conditions prevalent in 
Northern Australia as well as in Australian communities 
in general.
When we consider the patterns of infectious diseases 
found in this cohort, S. aureus was the most common 
pathogen identified followed by influenza and Group A 
streptococcus. Skin and soft tissue was the most common 
site of infection followed by the respiratory tract. Future 
analysis of patient factors associated with mortality is 
underway. These data will allow comparison with other 
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Figure 1 Representation of relational database constructed showing links between fields from incorporated administrative, 
clinical and death registry information. (see online supplementary table S1 for detailed description of fields).
mortality data from Australian studies of infectious 
diseases.
All- cause mortality rates from Australian cohorts of 
patients with selected, highly morbid, infections such 
as S. aureus bacteraemia (28%, 2–5 year follow- up),7 
community- acquired pneumonia (60.4%, mean follow- up 
6.1 years)8 and infective endocarditis (14.7%, 1–5 year 
follow- up) have been described.9 These studies all 
demonstrated increased all- cause mortality of the infec-
tious diseases cohorts compared with controls.
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Table 1 Cohort characteristics (n=41 367)
Characteristics No Mean Median SD Q1 Q3
Age (years) at first admission 41 367 43.15 49 24.44 26 68
Total admissions 378 487 9.15 2 60.74 1 5
Demographics Patients Percentage
  Male 21 299 51.49
  Female 20 068 48.51
11- year mortality     
  Dead 8274 20
Indigenous status   
  Aboriginal but not TSI* origin 4763 11.51
  Aboriginal and TSI 550 1.33
  Neither Aboriginal nor TSI 35 187 85.06
  TSI but not Aboriginal 721 1.74
Correctional facility 1853 4.47
  Aboriginal but not TSI origin 1450 78.25
  Aboriginal and TSI 8 0.43
  Neither Aboriginal nor TSI 402 21.69
  TSI but not Aboriginal 32 1.73
Lifestyle
  Smoking 18 179 43.95
  Alcohol 4743 11.47
  Recreational drug use 600 1.45
  Malnutrition 4605 11.13
  Obesity 1633 3.95
*Aboriginal and Torres Strait Islander.
This cohort will allow a wide range of future analyses 
on the epidemiology of severe infection in patients of the 
largest tertiary referral hospital in Northern Australia. 
Its size and complexity makes it a valuable resource. The 
variety of data that are incorporated allow for nuanced 
study of inpatients discharged with an infectious diagnosis. 
For example, linkage of microbiological, haematological 
and biochemical provides the opportunity to correlate 
numerous laboratory parameters with disease outcomes. 
Emergency department data will facilitate assessment of 
the numbers of hospital presentations made prior to a 
diagnosis such as cryptococcal meningitis. In a recent 
study based on a cohort of inpatients with pnuemonia 
extracted from this data linkage, we found an immediate 
increase in risk of pneumonia associated with exposure 
to moderate low temperatures in late winter and early 
summer.10
There has been a sustained increase in the numbers of 
cohort studies using linked administrative hospital data 
sets, including in Australia.11 However, infectious diseases 
studies are in the minority compared with cardiovascular, 
health services, cancer and maternal health research. 
Australian cohort studies that use data linkage to describe 
infectious diseases mostly rely on ICD-10- AM diagnostic 
codes and death registry information. Some also incorpo-
rate notifiable diseases data12 but, overall, studies incor-
porating pathology data are few.13 14
Regrettably, in Australian jurisdictions, pathology data 
are only available for data linkage in Western Australia 
and Queensland due to their statewide diagnostic labora-
tories.4 Data- linkage studies incorporating pathology data 
have tested the precision of infectious diseases diagnosis 
in comparison with public health communicable diseases 
notifications systems15 and hospital discharge coding.13 
These studies both demonstrated underascertainment of 
childhood respiratory tract diseases.
Australian infectious diseases cohort studies have 
involved: organ specific infections such as respiratory 
viral infections,13 infections such as Q fever12 and S. 
aureus bacteraemia14 as well as specific patients such as 
asplenics16 and haematology–oncology.17 The value of 
Australian patient cohorts for infectious diseases research 
is further shown by the multiple studies deriving from the 
45 and up study of ageing,18 Triple I Western Australian 
birth cohort15 and Victorian Post- Splenectomy Registry.19
There are inherent limitations of retrospective databases 
defined by ICD-10- AM codes. Some important clinical 
information is underrepresented. This is exemplified in 
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Table 2 Major comorbidities and Charlson Comorbidity 
Index
Major comorbidities n %
Myocardial infarction 3042 7.35
Peripheral vascular disease 1862 4.50
Cerebrovascular disease 3294 7.96
Heart failure 1754 4.24
Dementia 790 1.91
Chronic pulmonary disease 5140 12.42
Rheumatic disease 475 1.15
Peptic ulcer disease 568 1.37
Mild liver disease 1992 4.82
Moderate or severe liver disease 612 1.48
Diabetes without chronic 
complication
5131 12.40
Diabetes with chronic complication 5102 12.33
Hemiplegia or paraplegia 1907 4.61
Renal disease 7419 17.93
Any malignancy, including lymphoma 
and leukaemia, except malignant 
neoplasm of skin
5602 13.54
Metastatic solid tumour 1203 2.91
AIDS/HIV 114 0.26
Charlson Comorbidity Index (CCI)
  None: CCI score (0) 21 215 51.28
  Mild: CCI score (1–2) 8270 19.99
  Moderate: CCI score (3–4) 5492 15.28
  Severe: CCI score (5+) 6390 15.45
  Median (IQR) 0 (0–3)
  Mean (SD) 1.86 (2.72)
Figure 2 Heat map of cohort patients per 100 000 shown 
by postcode of domicile according to hospital registration at 
entry into cohort.
this cohort study where only 3.95% of patients were coded 
as being obese. By contrast, among the general Australian 
population, as measured in 2017–2018, 31% of adults and 
8.6% of children and adolescents were obese.20 This inpa-
tient underestimate may derive from ICD-10- AM coding 
for obesity only being allocated where active assessment is 
made by a dietitian for obesity. Inpatients at the Townsville 
Hospital were more frequently diagnosed (11.13%) with 
malnutrition reflecting documentation of clinical inter-
ventions. The administrative databases used to construct 
this linked database predated use of an electronic medical 
record at Townsville Hospital. Machine learning is being 
used in research settings to analyse free text in clinical 
notes and diagnostic imaging reports.21 However, owing to 
absence of free text data, we are unable to apply this meth-
odology to our database. The absence of this clinical infor-
mation may diminish the ability to determine precise case 
definitions and important comorbidities such as obesity.
Despite these potential limitations, ICD-10- AM codes 
for infectious diseases have been shown to be closely 
correlated with clinical diagnoses determined after 
medical chart review in Australian research, for example, 
in two studies of community- acquired pneumonia.22 23 
Linked administrative data was shown to reliably ascer-
tain incident colorectal and lung cancer diagnoses when 
compared with the New South Wales Cancer Registry.24 
Other Australian researchers have studied the accuracy 
of ICD-10- AM codes for diagnoses of childhood influ-
enza and pertussis.25 While demonstrating high speci-
ficity and positive predictive value, the authors conclude 
that addition of laboratory data increases the precision 
of retrospective, population level diagnosis of paediatric 
respiratory infection. The incorporation of pathology 
results in the cohort described in this database will allow 
precise characterisation of the infectious diseases cohort 
we have assembled. For example, the large volume of 
microbiology data will allow for analysis of key areas such 
as antimicrobial resistant infections and their influence 
on clinical outcomes and provide greater precision for 
diagnosis (eg, site of infection in sepsis).
ConCluSIonS
Numerous analysis of risks for, and outcomes of, disease 
and organism- specific infections, healthcare costs and anti-
microbial side effects will all be undertaken in the future 
using these data. These studies will incorporate measures 
such as the Socio- Economic Index for Areas26 to assess the 
7Eisen DP, et al. BMJ Open 2020;10:e034845. doi:10.1136/bmjopen-2019-034845
Open access
Table 3 Total cases of diseases due to selected microbial 
pathogens
Diseases N
Staphylococcus aureus sepsis 6802
  Skin and soft tissue infection 3182
  Osteomyelitis 670
  Arthritis 215
  Phlebitis and thrombophlebitis 250
  Infective endocarditis 172
Streptococcus pyogenes infection 1197
  Skin and soft tissue infection 693
Streptococcus pneumoniae sepsis 515
  Pneumonia 435
Urinary tract infection
  Pyelonephritis 1391
  Cystitis 314
  Urethritis 22
  Prostatitis 118
  Abscess 52
  Other 9083
Pneumonia
  Viral 769
  Bacterial 2853
  Other 4151
Influenza 1738
Meningitis
  Viral 240
  Bacterial 123
Tropical infection
  Melioidosis 84
  Dengue 88
  Ross River 48
  Q fever 139
impact of socioeconomic disadvantage on outcomes of 
infectious diseases occurring in hospitalised patients. As 
hospitalisation data are available before the admission that 
led the patient to be included in the cohort, there will be an 
opportunity to assess presentations and investigation find-
ings that predated diagnosis. Similarly, the extensive infor-
mation from subsequent hospitalisations will allow detailed 
analysis of long- term health effects after severe infectious 
diseases. The use of linked pathology data may retrospec-
tively improve definition of severe infectious diseases such 
as invasive group A streptococcal infection by a systematic 
search for positive cultures from sterile sites.
Strengths and limitations of this study
The main strength of this cohort is its large size and unique 
description of inpatients diagnosed with infectious diseases 
at an Australian tropical zone hospital. The intricate 
relational database has provided a resource that can be 
easily searched. In future analyses, the linkage of numerous 
data sources to provide a granular description of patient 
disease and treatment will enable the use of a variety of 
statistical methods. Similarly, pathology and pharmacy anti-
microbial dispensing data availability allows for precise case 
definition and analysis of treatment response.
The main study limitations are that it is based on data 
sets from a single hospital so future findings will not be 
applicable to the general Australian population and the 
validity of cohort studies rely on the accuracy of clinical 
coding. Despite these limitations, this database will be a 
rich source of information for future cohort studies of the 
epidemiology of infectious diseases in the catchment area 
of the only tertiary hospital in North Queensland.
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